Growing community of inventors

Stuttgart, Germany

Philipp Wagner

Average Co-Inventor Count = 4.36

ph-index = 8

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 115

Philipp Wagner ↔ Heiko Schuster (24 patents)Philipp Wagner ↔ Hans-Georg Rammensee (24 patents)Philipp Wagner ↔ Janet Peper (23 patents)Philipp Wagner ↔ Kevin Roehle (9 patents)Philipp Wagner ↔ Kevin Röhle (1 patent)Philipp Wagner ↔ Janet Peper (1 patent)Philipp Wagner ↔ Kevin RÖHLE (0 patent)Philipp Wagner ↔ Hans-georg Rammensee (0 patent)Philipp WagnerPhilipp Wagner (24 patents)Heiko SchusterHeiko Schuster (152 patents)Hans-Georg RammenseeHans-Georg Rammensee (68 patents)Janet PeperJanet Peper (26 patents)Kevin RoehleKevin Roehle (11 patents)Kevin RöhleKevin Röhle (2 patents)Janet PeperJanet Peper (1 patent)Kevin RÖHLEKevin RÖHLE (0 patent)Hans-georg RammenseeHans-georg Rammensee (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Immatics Biotechnologies Gmbh (23 from 725 patents)


24 patents:

1. 12098183 - Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

2. 12065477 - Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

3. 11919940 - Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

4. 11858978 - Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

5. 11840562 - Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

6. 11819518 - Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers

7. 11806366 - Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers

8. 11345737 - Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

9. 11278571 - Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers

10. 11246889 - Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers

11. 11248035 - Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

12. 11214608 - Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

13. 11078253 - Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

14. 11071756 - Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers

15. 11053296 - Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/16/2025
Loading…